Group One Trading’s Genomic Health, Inc. GHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-7,900
Closed -$536K 5962
2019
Q3
$536K Buy
+7,900
New +$543K ﹤0.01% 2277
2018
Q4
Sell
-200
Closed -$14K 5751
2018
Q3
$14K Hold
200
﹤0.01% 4554
2018
Q2
$10K Sell
200
-800
-80% -$31.7K ﹤0.01% 4636
2018
Q1
$31K Hold
1,000
﹤0.01% 3903
2017
Q4
$34K Buy
+1,000
New +$31.9K ﹤0.01% 3931
2016
Q1
Sell
-4,000
Closed -$141K 5200
2015
Q4
$141K Buy
4,000
+3,300
+471% +$88.4K ﹤0.01% 2759
2015
Q3
$15K Hold
700
﹤0.01% 4168
2015
Q2
$19K Buy
+700
New +$19.7K ﹤0.01% 4058
2014
Q4
Sell
-100
Closed -$3K 5481
2014
Q3
$3K Sell
100
-200
-67% -$5.58K ﹤0.01% 4875
2014
Q2
$8K Sell
300
-3,500
-92% -$93.2K ﹤0.01% 4616
2014
Q1
$100K Buy
3,800
+3,600
+1,800% +$103K ﹤0.01% 3089
2013
Q4
$6K Sell
200
-2,500
-93% -$79.3K ﹤0.01% 4812
2013
Q3
$83K Buy
2,700
+1,900
+238% +$63.5K ﹤0.01% 3177
2013
Q2
$25K Buy
+800
New +$26.3K ﹤0.01% 3950

Group One Trading's GHDX Position: Q3 2019 in Review

Group One Trading sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 2,131 shares — an estimated $146K sold.

Group One Trading first reported a position in GHDX in Q2 2013 and held it in 11 quarters. The position peaked at $385K in Q1 2015. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

  • Group One Trading reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
  • Group One Trading sold 2,131 Genomic Health, Inc. shares in Q3 2019, an estimated $146K.
  • Group One Trading first reported a position in Genomic Health, Inc. in Q2 2013 and held it in 11 quarters.
  • Group One Trading's Genomic Health, Inc. position peaked at $385K in Q1 2015.
  • 221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Group One Trading's 13F filing for Q3 2019, filed 12 Nov 2019.